{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:36:12Z","timestamp":1792290972057,"version":"4.4.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.neuropharm.2016.02.010","type":"journal-article","created":{"date-parts":[[2016,2,14]],"date-time":"2016-02-14T20:56:58Z","timestamp":1455483418000},"page":"478-486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Modulatory effects of the basolateral amygdala \u03b12-adrenoceptors on nicotine-induced anxiogenic-like behaviours of rats in the elevated plus maze"],"prefix":"10.1016","volume":"105","author":[{"given":"Hamideh","family":"Bashiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameneh","family":"Rezayof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mousa","family":"Sahebgharani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mohammad","family":"Tavangar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad-Reza","family":"Zarrindast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2016.02.010_bib1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fnbeh.2015.00031","article-title":"Behavior in the elevated plus maze is differentially affected by testing conditions in rats under and over three weeks of age","volume":"9","author":"Albani","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib2","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1111\/bph.13090","article-title":"Anxiolytic-like and anxiogenic-like effects of nicotine are regulated via diverse action at \u03b22*nicotinic acetylcholine receptors","volume":"172","author":"Anderson","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib3","series-title":"The Catecholaminergic Innervation of the Rat Amygdala","author":"Asan","year":"2013"},{"key":"10.1016\/j.neuropharm.2016.02.010_bib4","first-page":"627","article-title":"Anxiolytic and antidepressant-like activities of the novel and potent non-imidazole histamine H\u2083 receptor antagonist ST-1283","volume":"28","author":"Bahi","year":"2014","journal-title":"Drug Des. Devel Ther."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0014-2999(89)90709-7","article-title":"Antagonistic effects of caffeine and yohimbine in animal tests of anxiety","volume":"159","author":"Baldwin","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib6","first-page":"113","article-title":"Effects of the cannabinoid receptor ligands on anxiety-related effects of d-amphetamine and nicotine in the mouse elevated plus maze test","volume":"60","author":"Biala","year":"2009","journal-title":"Acta Physiol. Pol."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib7","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0022-3565(25)13203-5","article-title":"Alpha-2 adrenergic inhibition of Ca(++)-evoked [3H]norepinephrine release from synaptosomes is blocked by depolarization","volume":"253","author":"Bowyer","year":"1990","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib8","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.pbb.2010.09.013","article-title":"Comparison of the elevated plus and elevated zero mazes in treated and untreated male Sprague-Dawley rats: effects of anxiolytic and anxiogenic agents","volume":"97","author":"Braun","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib9","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/0028-3908(91)90116-S","article-title":"Effect of acute administration of nicotine on in\u00a0vivo release of noradrenaline in the hippocampus of freely moving rats: a dose-response and antagonist study","volume":"30","author":"Brazell","year":"1991","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2016.02.010_bib10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/01.yic.0000073880.93678.68","article-title":"Noradrenaline in mood and anxiety disorders: basic and clinical studies","volume":"18","author":"Brunello","year":"2003","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib11","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0306-4522(01)00531-0","article-title":"Two \u03b1 2-adrenergic receptor subtypes, \u03b1 2A and \u03b1 2C, inhibit transmitter release in the brain of gene-targeted mice","volume":"109","author":"B\u00fccheler","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2016.02.010_bib12","doi-asserted-by":"crossref","first-page":"12358","DOI":"10.1523\/JNEUROSCI.2007-07.2007","article-title":"Noradrenergic modulation of basolateral amygdala neuronal activity: opposing influences of alpha-2 and beta receptor activation","volume":"27","author":"Buffalari","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib13","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.neuroscience.2009.07.003","article-title":"Anxiogenic modulation of spontaneous and evoked neuronal activity in the basolateral amygdala","volume":"163","author":"Buffalari","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2016.02.010_bib14","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/00006842-200007000-00014","article-title":"Effects of yohimbine on cerebral blood flow, symptoms, and physiological functions in humans","volume":"62","author":"Cameron","year":"2000","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib15","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.neubiorev.2005.04.017","article-title":"Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on","volume":"29","author":"Carobrez","year":"2005","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0024-3205(83)90707-5","article-title":"Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine","volume":"33","author":"Charney","year":"1983","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib17","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1046\/j.1460-9568.2000.00246.x","article-title":"The role of 5-HT1A receptors in mediating the anxiogenic effects of nicotine following lateral septal administration","volume":"12","author":"Cheeta","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0091-3057(01)00641-4","article-title":"Antagonism of the anxiolytic effect of nicotine in the dorsal raphe nucleus by dihydro-beta-erythroidine","volume":"70","author":"Cheeta","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib19","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00213-009-1486-7","article-title":"Anxiolytic effects of nicotine in a rodent test of approach-avoidance conflict","volume":"204","author":"Cohen","year":"2009","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib20","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/syn.20914","article-title":"The effects of nicotine and cigarette smoke on the monoamine transporters","volume":"65","author":"Danielson","year":"2011","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2016.02.010_bib21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/sj.npp.1300324","article-title":"Activation of a (2) adrenergic receptors suppresses fear conditioning: expression of c-Fos and phosphorylated CREB in mouse amygdala","volume":"29","author":"Davies","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2016.02.010_bib22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/npp.2009.109","article-title":"Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety","volume":"35","author":"Davis","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2016.02.010_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/hup.1074","article-title":"Serotonin norepinephrine reuptake inhibitors (SNRIs) in anxiety disorders: a comprehensive review of their clinical efficacy","volume":"25","author":"Dell'osso","year":"2010","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib24","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1001\/archgenpsychiatry.2009.104","article-title":"Disrupted amygdalar subregion functional connectivity and evidence of a compensatory network in generalized anxiety disorder","volume":"66","author":"Etkin","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2016.02.010_bib25","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.drugalcdep.2011.09.001","article-title":"Nicotine self-administration and reinstatement of nicotine-seeking in male and female rats","volume":"121","author":"Feltenstein","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib26","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1101\/lm.760908","article-title":"Involvement of basolateral amygdala alpha2-adrenoceptors in modulating consolidation of inhibitory avoidance memory","volume":"15","author":"Ferry","year":"2008","journal-title":"Learn Mem."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib27","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1037\/0735-7044.112.6.1423","article-title":"Bimodal modulation by nicotine of anxiety in the social interaction test: role of the dorsal hippocampus","volume":"112","author":"File","year":"1998","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.beproc.2014.08.005","article-title":"Aversion in the elevated plus-maze: role of visual and tactile cues","volume":"107","author":"Filgueiras","year":"2014","journal-title":"Behav. Process."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib29","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/(SICI)1097-4547(19971215)50:6<1040::AID-JNR15>3.0.CO;2-8","article-title":"Regulation of norepinephrine release from the rat bed nucleus of the stria terminalis: in\u00a0vivo microdialysis studies","volume":"50","author":"Forray","year":"1997","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib30","series-title":"The Role of the Amygdala in Anxiety Disorders","author":"Forster","year":"2012"},{"key":"10.1016\/j.neuropharm.2016.02.010_bib31","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S0022-3565(24)37341-0","article-title":"Nicotine-induced norepinephrine release in the rat amygdala and hippocampus is mediated through brainstem nicotinic cholinergic receptors","volume":"284","author":"Fu","year":"1998","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib32","first-page":"275","article-title":"Effect of adrenergic antagonists and cyclooxygenase inhibitors on the nicotine-induced hypothalamic-pituitary-adrenocortical activity","volume":"53","author":"Gadek-Michalska","year":"2002","journal-title":"J.\u00a0Physiol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fpsyt.2015.00041","article-title":"Role of the endogenous cannabinoid system in nicotine addiction: novel insights","volume":"6","author":"Gamaleddin","year":"2015","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.neuropharm.2016.02.010_bib34","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1471-4159.2004.02748.x","article-title":"Autoreceptor-mediated inhibition of norepinephrine release in rat medial prefrontal cortex is maintained after chronic desipramine treatment","volume":"91","author":"Garcia","year":"2004","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib35","first-page":"1","article-title":"Neurochemical modulation of anxiety disorders","volume":"2","author":"Gilhotra","year":"2010","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib36","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1523\/JNEUROSCI.5095-09.2010","article-title":"Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area \u03b16\u03b22* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement","volume":"30","author":"Gotti","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib37","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0893-133X(98)00062-1","article-title":"Adrenergic receptor function in panic disorder: I. platelet \u03b12 receptors Gi protein coupling, effects of imipramine, and relationship to treatment outcome","volume":"20","author":"Gurguis","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2016.02.010_bib38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0091-3057(95)02126-4","article-title":"A\u00a0review of the validity and variability of the elevated plus-maze as an animal model of anxiety","volume":"54","author":"Hogg","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib39","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1017\/S0033291709992376","article-title":"Human amygdala reactivity is diminished by the \u03b2-noradrenergic antagonist propranolol","volume":"40","author":"Hurlemann","year":"2010","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib40","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1152\/jn.1995.74.6.2427","article-title":"Extranuclear dendrites of locus coeruleus neurons: activation by glutamate and modulation of activity by alpha adrenoceptors","volume":"74","author":"Ivanov","year":"1995","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib41","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0091-3057(01)00683-9","article-title":"Behavioral reactivity to stress: amplification of stress-induced noradrenergic activation elicits a galanin-mediated anxiolytic effect in central amygdala","volume":"71","author":"Khoshbouei","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib42","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0306-4522(02)00185-9","article-title":"Behavioral and neurochemical characterization of \u03b1 2A-adrenergic receptor knockout mice","volume":"113","author":"L\u00e4hdesm\u00e4ki","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2016.02.010_bib43","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/brb3.287","article-title":"Intrathecal administrationof clonidine or yohimbine decreases the nociceptive behavior caused by formalininjection in the marsh terrapin (Pelomedusa subrufa)","volume":"4","author":"Makau","year":"2014","journal-title":"Brain Behav."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib44","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.physbeh.2011.04.052","article-title":"Cholinergic modulation of mesolimbic dopamine function and reward","volume":"104","author":"Mark","year":"2011","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib45","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1210\/endo-127-4-1646","article-title":"Catecholamines mediate nicotine-induced adrenocorticotropin secretion via a-adrenergic receptors*","volume":"127","author":"Matta","year":"1990","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2016.02.010_bib46","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0022-3565(24)39023-8","article-title":"S18616, a highly potent spiroimidazoline agonist at \u03b12-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine","volume":"295","author":"Millan","year":"2000","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib47","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.2105\/AJPH.2012.300911","article-title":"Cigarette smoking and onset of mood and anxiety disorders","volume":"103","author":"Mojtabai","year":"2013","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.neuropharm.2016.02.010_bib48","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.brainres.2004.08.057","article-title":"Noradrenergic \u03b1-2 agonists have anxiolytic-like actions on stress-related behavior and mesoprefrontal dopamine biochemistry","volume":"1027","author":"Morrow","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib49","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/cne.20727","article-title":"The anxiogenic drug yohimbine activates central viscerosensory circuits in rats","volume":"492","author":"Myers","year":"2005","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib50","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.tvjl.2006.12.013","article-title":"Pathological anxiety in animals","volume":"175","author":"Ohl","year":"2008","journal-title":"Vet. J."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib51","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1210\/endo.131.3.1505468","article-title":"Hypercortisolemia inhibits yohimbine-induced release of norepinephrine in the posterolateral hypothalamus of conscious rats","volume":"131","author":"Pacak","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2016.02.010_bib52","series-title":"The Rat Brain: in Stereotaxic Coordinates","first-page":"456","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.neuropharm.2016.02.010_bib53","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-3565(24)29397-6","article-title":"\u03b11-Adrenergic receptors: new insights and directions","volume":"298","author":"Piascik","year":"2001","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib54","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0165-6147(03)00230-X","article-title":"Nicotine as a modulator of behavior: beyond the inverted U","volume":"24","author":"Picciotto","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib55","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0893-133X(99)00146-3","article-title":"Nicotinic receptors in the brain: links between molecular biology and behavior","volume":"22","author":"Picciotto","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2016.02.010_bib56","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/00001756-200207020-00006","article-title":"Effect of nicotine and nicotinic receptors on anxiety and depression","volume":"13","author":"Picciotto","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2016.02.010_bib57","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0006-8993(01)02553-7","article-title":"The release of noradrenaline in the locus coeruleus and prefrontal cortex studied with dual-probe microdialysis","volume":"906","author":"Pudovkina","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib58","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.bbr.2009.03.030","article-title":"Effects of morphine on rat behaviour in the elevated plus maze: the role of central amygdala dopamine receptors","volume":"202","author":"Rezayof","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib59","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0149-7634(96)00058-9","article-title":"Anxiety, defence and the elevated plus-maze","volume":"21","author":"Rodgers","year":"1997","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib60","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0091-3057(95)00138-M","article-title":"Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety","volume":"52","author":"Rodgers","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib61","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11064-004-9690-7","article-title":"Regional heterogeneity of nicotine effects on neurotransmitters in rat brains in\u00a0vivo at low doses","volume":"30","author":"Rossi","year":"2005","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib62","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1523\/JNEUROSCI.21-13-04875.2001","article-title":"The \u03b12A-adrenergic receptor plays a protective role in mouse behavioral models of depression and anxiety","volume":"21","author":"Schramm","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib63","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejphar.2004.11.044","article-title":"Effects of clonidine injections into the bed nucleus of the stria terminalis on fear and anxiety behavior in rats","volume":"507","author":"Schweimer","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib64","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/pro.5560020802","article-title":"Structure, function, and regulation of adrenergic receptors","volume":"2","author":"Strosberg","year":"1993","journal-title":"Protein Sci."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib65","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0091-3057(01)00548-2","article-title":"The anxiolytic-like effect of nicotine undergoes rapid tolerance in a model of contextual fear conditioning in rats","volume":"69","author":"Szyndler","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib66","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0091-3057(93)90492-C","article-title":"Anxiogenic stimuli in the elevated plus-maze","volume":"44","author":"Treit","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib67","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0028-3908(02)00391-X","article-title":"Methyllycaconitine (MLA) blocks the nicotine evoked anxiogenic effect and 5-HT release in the dorsal hippocampus: possible role of alpha7 receptors","volume":"44","author":"Tucci","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2016.02.010_bib68","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neulet.2011.05.231","article-title":"Novelty response of rats determines the effect of prefrontal alpha-2 adrenoceptor modulation on anxiety","volume":"499","author":"Uzsoki","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib69","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nprot.2007.44","article-title":"The use of the elevated plus maze as an assay of anxiety-related behavior in rodents","volume":"2","author":"Walf","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib70","series-title":"WHO Report on the Global Tobacco Epidemic 2013","author":"WHO.","year":"2013"},{"key":"10.1016\/j.neuropharm.2016.02.010_bib71","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.neuropharm.2010.09.013","article-title":"Stimulation of \u03b12-adrenergic receptors in the central nucleus of the amygdala attenuates stress-induced reinstatement of nicotine seeking in rats","volume":"60","author":"Yamada","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2016.02.010_bib72","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neuropharm.2013.06.027","article-title":"FG7142, yohimbine, and \u03b2CCE produce anxiogenic-like effects in the elevated plus-maze but do not affect brainstem activated hippocampal theta","volume":"75","author":"Yeung","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2016.02.010_bib73","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1177\/0269881111412094","article-title":"Nicotine-induced anxiogenic-like behaviours of rats in the elevated plus-maze: possible role of NMDA receptors of the central amygdala","volume":"26","author":"Zarrindast","year":"2012","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib74","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejphar.2013.01.023","article-title":"Effects of dopamine receptor agonist and antagonists on cholestasis-induced anxiolytic-like behaviors in rats","volume":"702","author":"Zarrindast","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib75","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0014-2999(00)00628-2","article-title":"Involvement of adrenergic and cholinergic systems in nicotine-induced anxiogenesis in mice","volume":"407","author":"Zarrindast","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib76","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.brainres.2012.04.036","article-title":"Involvement of rat dopaminergic system of nucleus accumbens in nicotine-induced anxiogenic-like behaviors","volume":"1460","author":"Zarrindast","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib77","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000161129","article-title":"Effect of intra-amygdala injection of nicotine and GABA receptor agents on anxiety-like behaviour in rats","volume":"82","author":"Zarrindast","year":"2008","journal-title":"Pharmacology"},{"key":"10.1016\/j.neuropharm.2016.02.010_bib78","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.physbeh.2013.06.004","article-title":"Role of the medial septum cholinoceptors in anxiogenic-like effects of nicotine","volume":"119","author":"Zarrindast","year":"2013","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib79","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1124\/jpet.106.112474","article-title":"Nicotine-induced norepinephrine release in hypothalamic paraventricular nucleus and amygdala is mediated by N-methyl-D-aspartate receptors and nitric oxide in the nucleus tractus solitarius","volume":"320","author":"Zhao","year":"2007","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2016.02.010_bib80","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.neuropharm.2007.09.007","article-title":"Effects of the CRF receptor antagonist d-Phe CRF (12\u201341) and the \u03b12-adrenergic receptor agonist clonidine on stress-induced reinstatement of nicotine-seeking, in rats","volume":"53","author":"Zislis","year":"2007","journal-title":"Neuropharmacology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390816300454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390816300454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:50:46Z","timestamp":1758437446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390816300454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":80,"alternative-id":["S0028390816300454"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.02.010","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulatory effects of the basolateral amygdala \u03b12-adrenoceptors on nicotine-induced anxiogenic-like behaviours of rats in the elevated plus maze","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}